Stephen T. Keir

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas”.

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas

Nature Communications(2024)10.1038/s41467-024-44932-w

N/A

0.779DataRank · unranked

24 citations

Benjamin T. Whitfield, Christopher J. Pirozzi, Matthew S. Waitkus, Michael C. Brown, Michelle Bowie +22 more

The multilayered transcriptional architecture of glioblastoma ecosystems

Nature Genetics(2025)10.1038/s41588-025-02167-5

N/A

0.686DataRank · unranked

96 citations

Avishay Spitzer, Kevin C. Johnson, Luciano Garofano, Djamel Nehar-Belaid, Noam Galili Darnell +41 more

Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics

Nature Genetics(2025)10.1038/s41588-025-02168-4

N/A

0.626DataRank · unranked

64 citations

Kevin C. Johnson, Masashi Nomura, Luciano Garofano, Djamel Nehar-Belaid, Noam Galili Darnell +41 more

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.20.537594

N/A

0.104DataRank · unranked

1 citations

Benjamin T. Whitfield, Christopher J. Pirozzi, Matthew S. Waitkus, Michael C. Brown, Michelle Bowie +22 more

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Cancers(2023)10.3390/cancers15184619

N/A

0DataRank · unranked

5 citations

Rui Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu +12 more

Data from A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

(2023)10.1158/1078-0432.c.6531102.v1

N/A

0DataRank · unranked

0 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more

A Modified Nucleoside 6-Thio-2′-Deoxyguanosine Exhibits Antitumor Activity in Gliomas

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0374

N/A

0DataRank · unranked

30 citations

Shiyou Wei, Milan R. Savani, Xiang Lin, Kuang Du, Ilgen Mender +33 more

Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-1098

N/A

0DataRank · unranked

6 citations

Adebimpe Adefolaju, Casey Fraley, Mariah Shobande, Rajaneekar Dasari, Breanna Mann +8 more

Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.19.507319

N/A

0DataRank · unranked

0 citations

Cheng Xu, Bill H. Diplas, Alexandrea Brown, Laura M. Strickland, Jinjie Ling +6 more

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005871

N/A

0DataRank · unranked

62 citations

Johanna Theruvath, David Pauck, Daniel Picard, Nan Qin, Lena Blümel +33 more

Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells

Neuro-Oncology(2023)10.1093/neuonc/noad022

N/A

0DataRank · unranked

27 citations

Cheng Xu, Bill H. Diplas, Alexandrea Brown, Laura M. Strickland, Haipei Yao +7 more